Diabetes care
GLP-1 Receptor Agonists and Risk of Optic Nerve or Vision-Threatening Events in Patients With Type 2 Diabetes or Cardiometabolic Diseases: A Meta-analysis of Randomized Controlled Trials.
Hoi-Ying Li, Tsz-Kwan Chan, Kendrick Co Shih, Bernard M Y Cheung, Kai-Hang Yiu, Hung-Fat Tse, Yap-Hang Chan
Published: 202610.2337/dc25-1929
Abstract
BACKGROUND: Data concerning glucagon-like peptide 1 receptor agonists (GLP-1 RAs) on risk of ischemic optic neuropathy (ION) are conflicting. PURPOSE: We synthesize current evidence of GLP-1 RAs on risk of optic nerve or vision-threatening events fro…
Preview only. Read the full abstract at the source